These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34812584)

  • 1. Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles.
    Perluigi M; Picca A; Montanari E; Calvani R; Marini F; Matassa R; Tramutola A; Villani A; Familiari G; Domenico FD; Butterfield DA; Oh KJ; Marzetti E; Valentini D; Barone E
    Alzheimers Dement; 2022 Aug; 18(8):1498-1510. PubMed ID: 34812584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.
    Perluigi M; Pupo G; Tramutola A; Cini C; Coccia R; Barone E; Head E; Butterfield DA; Di Domenico F
    Biochim Biophys Acta; 2014 Jul; 1842(7):1144-53. PubMed ID: 24735980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome.
    Tramutola A; Lanzillotta C; Di Domenico F; Head E; Butterfield DA; Perluigi M; Barone E
    Neurobiol Dis; 2020 Apr; 137():104772. PubMed ID: 31987911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR Hyperactivation in down syndrome hippocampus appears early during development.
    Iyer AM; van Scheppingen J; Milenkovic I; Anink JJ; Adle-Biassette H; Kovacs GG; Aronica E
    J Neuropathol Exp Neurol; 2014 Jul; 73(7):671-83. PubMed ID: 24918639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: A harmful synergistic path in down syndrome.
    Lanzillotta C; Tramutola A; Di Giacomo G; Marini F; Butterfield DA; Di Domenico F; Perluigi M; Barone E
    Free Radic Biol Med; 2021 Mar; 165():152-170. PubMed ID: 33516914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-signaling abnormalities in drug-naïve first-episode schizophrenia: Transduction protein analyses in extracellular vesicles of putative neuronal origin.
    Kapogiannis D; Dobrowolny H; Tran J; Mustapic M; Frodl T; Meyer-Lotz G; Schiltz K; Schanze D; Rietschel M; Bernstein HG; Steiner J
    Eur Psychiatry; 2019 Oct; 62():124-129. PubMed ID: 31590015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease.
    O' Neill C
    Exp Gerontol; 2013 Jul; 48(7):647-53. PubMed ID: 23470275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome.
    Di Domenico F; Tramutola A; Barone E; Lanzillotta C; Defever O; Arena A; Zuliani I; Foppoli C; Iavarone F; Vincenzoni F; Castagnola M; Butterfield DA; Perluigi M
    Redox Biol; 2019 May; 23():101162. PubMed ID: 30876754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down Syndrome iPSC-Derived Astrocytes Impair Neuronal Synaptogenesis and the mTOR Pathway In Vitro.
    Araujo BHS; Kaid C; De Souza JS; Gomes da Silva S; Goulart E; Caires LCJ; Musso CM; Torres LB; Ferrasa A; Herai R; Zatz M; Okamoto OK; Cavalheiro EA
    Mol Neurobiol; 2018 Jul; 55(7):5962-5975. PubMed ID: 29128905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD).
    Alldred MJ; Lee SH; Petkova E; Ginsberg SD
    Brain Struct Funct; 2015 Sep; 220(5):2983-96. PubMed ID: 25031177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).
    de la Monte SM
    J Alzheimers Dis; 2023; 95(4):1301-1337. PubMed ID: 37718817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging and intellectual disability: insights from mouse models of Down syndrome.
    Ruparelia A; Pearn ML; Mobley WC
    Dev Disabil Res Rev; 2013; 18(1):43-50. PubMed ID: 23949828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase.
    Mengel D; Liu W; Glynn RJ; Selkoe DJ; Strydom A; Lai F; Rosas HD; Torres A; Patsiogiannis V; Skotko B; Walsh DM
    Alzheimers Res Ther; 2020 Mar; 12(1):27. PubMed ID: 32192521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin.
    Mansur RB; Delgado-Peraza F; Subramaniapillai M; Lee Y; Iacobucci M; Nasri F; Rodrigues N; Rosenblat JD; Brietzke E; Cosgrove VE; Kramer NE; Suppes T; Raison CL; Fagiolini A; Rasgon N; Chawla S; Nogueras-Ortiz C; Kapogiannis D; McIntyre RS
    J Psychiatr Res; 2021 Jan; 133():82-92. PubMed ID: 33316649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.
    Dierssen M; Fructuoso M; Martínez de Lagrán M; Perluigi M; Barone E
    Front Neurosci; 2020; 14():670. PubMed ID: 32733190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.
    Di Domenico F; Coccia R; Cocciolo A; Murphy MP; Cenini G; Head E; Butterfield DA; Giorgi A; Schinina ME; Mancuso C; Cini C; Perluigi M
    Biochim Biophys Acta; 2013 Aug; 1832(8):1249-59. PubMed ID: 23603808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical aging in Down syndrome.
    Zigman WB
    Dev Disabil Res Rev; 2013; 18(1):51-67. PubMed ID: 23949829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain.
    Ahmed MM; Dhanasekaran AR; Tong S; Wiseman FK; Fisher EM; Tybulewicz VL; Gardiner KJ
    Hum Mol Genet; 2013 May; 22(9):1709-24. PubMed ID: 23349361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.